Page last updated: 2024-08-26

mizoribine and Necrosis

mizoribine has been researched along with Necrosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimoto, T; Hamaguchi, Y; Nishino, I; Suzuki, S; Tanaka, T	1
Kobayashi, T; Kuzuya, T; Liu, D; Ma, Y; Miwa, Y; Morozumi, K; Nagasaka, T; Nakao, A; Oikawa, T; Shimano, Y; Takeuchi, O; Uchida, K; Yokoyama, I	1
Arimura, K; Higuchi, I; Hokezu, Y; Inose, M; Izumo, S; Osame, M; Yoshimine, K	1

Trials

1 trial(s) available for mizoribine and Necrosis

Article	Year
[A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)]. Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:8 Topics: Adult; Aged; Anti-Inflammatory Agents; Atrophy; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle, Skeletal; Myositis; Necrosis; Paraparesis, Tropical Spastic; Prednisolone; Prognosis; Ribonucleosides; Treatment Outcome	1999

Article

Year

[A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)].

Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:8

Topics: Adult; Aged; Anti-Inflammatory Agents; Atrophy; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle, Skeletal; Myositis; Necrosis; Paraparesis, Tropical Spastic; Prednisolone; Prognosis; Ribonucleosides; Treatment Outcome

1999

Other Studies

2 other study(ies) available for mizoribine and Necrosis

Article	Year
What is the third serological marker associated with immune-mediated necrotizing myopathy? Scandinavian journal of rheumatology, 2017, Volume: 46, Issue:5 Topics: Aged, 80 and over; ATPases Associated with Diverse Cellular Activities; Autoantibodies; Autoimmunity; Biomarkers; Biopsy; Carrier Proteins; DNA Helicases; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Immunosuppressive Agents; Mitochondria, Muscle; Mitochondrial Proteins; Muscle, Skeletal; Muscular Diseases; Necrosis; Prednisolone; Reproducibility of Results; Ribonucleosides; Serologic Tests; Signal Recognition Particle; Treatment Outcome	2017
Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection. Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:4 Topics: Acute Disease; Animals; Biopsy; Creatinine; Dose-Response Relationship, Drug; Graft Rejection; Hemorrhage; Immunosuppressive Agents; Isoantibodies; Kidney Transplantation; Necrosis; Renal Insufficiency; Ribonucleosides; Salvage Therapy; Survival Analysis; Swine; Time Factors	2005

Article

Year

What is the third serological marker associated with immune-mediated necrotizing myopathy?

Scandinavian journal of rheumatology, 2017, Volume: 46, Issue:5

Topics: Aged, 80 and over; ATPases Associated with Diverse Cellular Activities; Autoantibodies; Autoimmunity; Biomarkers; Biopsy; Carrier Proteins; DNA Helicases; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Immunosuppressive Agents; Mitochondria, Muscle; Mitochondrial Proteins; Muscle, Skeletal; Muscular Diseases; Necrosis; Prednisolone; Reproducibility of Results; Ribonucleosides; Serologic Tests; Signal Recognition Particle; Treatment Outcome

2017

Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection.

Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:4

Topics: Acute Disease; Animals; Biopsy; Creatinine; Dose-Response Relationship, Drug; Graft Rejection; Hemorrhage; Immunosuppressive Agents; Isoantibodies; Kidney Transplantation; Necrosis; Renal Insufficiency; Ribonucleosides; Salvage Therapy; Survival Analysis; Swine; Time Factors

2005